Q32 Bio Inc. (QTTB) Shares Soar Above 1-Year High

Q32 Bio Inc. (NASDAQ: QTTB) has experienced a rise in its stock price by 22.11 compared to its previous closing price of 18.00. However, the company has seen a gain of 30.64% in its stock price over the last five trading days.

Is It Worth Investing in Q32 Bio Inc. (NASDAQ: QTTB) Right Now?

The 36-month beta value for QTTB is also noteworthy at -0.07. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for QTTB is 3.23M, and at present, short sellers hold a 0.59% of that float. The average trading volume of QTTB on April 03, 2024 was 22.23K shares.

QTTB’s Market Performance

The stock of Q32 Bio Inc. (QTTB) has seen a 30.64% increase in the past week, with a 36.73% rise in the past month, and a 100.84% gain in the past quarter. The volatility ratio for the week is 13.50%, and the volatility levels for the past 30 days are at 7.34% for QTTB. The simple moving average for the past 20 days is 33.77% for QTTB’s stock, with a 34.58% simple moving average for the past 200 days.

Analysts’ Opinion of QTTB

Robert W. Baird, on the other hand, stated in their research note that they expect to see QTTB reach a price target of $1.50, previously predicting the price at $9. The rating they have provided for QTTB stocks is “Neutral” according to the report published on July 28th, 2023.

BTIG Research gave a rating of “Neutral” to QTTB, setting the target price at $29 in the report published on February 22nd of the previous year.

QTTB Trading at 51.00% from the 50-Day Moving Average

After a stumble in the market that brought QTTB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -17.49% of loss for the given period.

Volatility was left at 7.34%, however, over the last 30 days, the volatility rate increased by 13.50%, as shares surge +36.94% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +108.52% upper at present.

During the last 5 trading sessions, QTTB rose by +30.64%, which changed the moving average for the period of 200-days by +18.55% in comparison to the 20-day moving average, which settled at $16.73. In addition, Q32 Bio Inc. saw 100.84% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at QTTB starting from TZIANABOS ARTHUR, who sale 13,037 shares at the price of $0.57 back on Jan 09 ’24. After this action, TZIANABOS ARTHUR now owns 128,778 shares of Q32 Bio Inc., valued at $7,445 using the latest closing price.

Alloway Paul, the of Q32 Bio Inc., sale 7,280 shares at $0.57 during a trade that took place back on Jan 03 ’24, which means that Alloway Paul is holding 28,036 shares at $4,120 based on the most recent closing price.

Stock Fundamentals for QTTB

Equity return is now at value -90.02, with -42.26 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 7.25.

Conclusion

In summary, Q32 Bio Inc. (QTTB) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Related Posts